Publication details

Phase Ib safety trial of CVX-060, an intravenous humanized monoclonal CovX body inhibiting angiopoietin 2 (Ang-2), with axitinib in patients with previously treated metastatic renal cell cancer (RCC). Abstract No: 2533

Authors

GOLLERKERI Ashwin GORDON Michael S. BURKE John M. HAUKE Ralph TOMÁŠEK Jiří DONALD Richards A

Year of publication 2013
Type Appeared in Conference without Proceedings
Citation

You are running an old browser version. We recommend updating your browser to its latest version.

More info